# REMAP Trial for Optimizing Surgical Outcomes at UPMC

> **NCT03861767** · PHASE3 · TERMINATED · sponsor: **Matthew Neal MD** · enrollment: 302 (actual)

## Conditions studied

- Aging

## Interventions

- **DRUG:** Metformin ER
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03861767
- **Lead sponsor:** Matthew Neal MD
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-04-15
- **Primary completion:** 2022-09-23
- **Final completion:** 2022-09-23
- **Target enrollment:** 302 (ACTUAL)
- **Why stopped:** Not enough enrollment due to the COVID19 pandemic.
- **Last updated:** 2024-06-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03861767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03861767, "REMAP Trial for Optimizing Surgical Outcomes at UPMC". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03861767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*